๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical relevance in drug trials for Alzheimer's disease and related disorders

โœ Scribed by Alberto Spagnoli

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
280 KB
Volume
6
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

French recommendations for clinical drug
French recommendations for clinical drug trials in cognitive disorders of the elderly
โœ Dr. Bernard Michel; Roland Sambuc; Jean-Claude Scotto ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB ๐Ÿ‘ 1 views

## Abstract A consensus conference on the topic of clinical drug trials in cognitive disorders of the elderly was held in Marseille on January 28โ€“29, 1993. At the end of this conference, several recommendations were made. Drugs used in trials must be chosen according to solid neurobiological eviden

The ADAS-cog and clinically meaningful c
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
โœ Kenneth Rockwood; Sherri Fay; Mary Gorman ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 184 KB ๐Ÿ‘ 1 views

## Abstract ## Background A minimum 4โ€point change at 6 months on the Alzheimer's disease assessment scaleโ€cognitive subscale (ADASโ€cog) is deemed clinically important, but this cutโ€point has been little studied in relation to clinical meaningfulness. In an investigatorโ€initiated, clinical trial o

Endpoints for clinical trials evaluating
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease
โœ Geert R. D'Haens; Richard Fedorak; Marc Lรฉmann; Brian G. Feagan; Michael A. Kamm ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesions, an